7528660

Source:http://linkedlifedata.com/resource/pubmed/id/7528660

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0194810, umls-concept:C0449258, umls-concept:C1514307, umls-concept:C1521733, umls-concept:C2348519
pubmed:issue	3
pubmed:dateCreated	1995-1-31
pubmed:abstractText	10-30% of patients with T1/T2 prostate cancer submitted to radical prostatectomy ultimately fail. It may be important to detect failure as early as possible in order to evaluate the extent of recurrent/residual disease and initiate adjuvant therapy.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7512719
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen
pubmed:status	MEDLINE
pubmed:issn	0302-2838
pubmed:author	pubmed-author:Boccon-GibodL ALA, pubmed-author:Boccon-GibodLL, pubmed-author:Dauge-GeffroyM CMC, pubmed-author:MeulemansAA, pubmed-author:RaveryVV, pubmed-author:ToublancMM
pubmed:issnType	Print
pubmed:volume	26
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	197-201
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:7528660-Adult, pubmed-meshheading:7528660-Aged, pubmed-meshheading:7528660-Humans, pubmed-meshheading:7528660-Male, pubmed-meshheading:7528660-Middle Aged, pubmed-meshheading:7528660-Neoplasm Recurrence, Local, pubmed-meshheading:7528660-Predictive Value of Tests, pubmed-meshheading:7528660-Prognosis, pubmed-meshheading:7528660-Prostate-Specific Antigen, pubmed-meshheading:7528660-Prostatectomy, pubmed-meshheading:7528660-Prostatic Neoplasms, pubmed-meshheading:7528660-Seminal Vesicles
pubmed:year	1994
pubmed:articleTitle	Predictive value of pathological features for progression after radical prostatectomy.
pubmed:affiliation	Department of Urology, CHU Bichat, Paris, France.
pubmed:publicationType	Journal Article